Aspirin lowers the risk of death from covid-19 by up to 13.6%, says a new study published in the journal Jama Network Open. The study covered 112,269 patients who were hospitalized due to SARS-CoV-2 infection and was undertaken by scientists at George Washington University in the United States.
The study included the biggest data set of 112,269 patients with mild COVID-19 who were hospitalized. Patients recruited in the National COVID Cohort Collaborative (N3C) between January 1, 2020, and September 10, 2021, at 64 health systems across the United States, were included in the study.
When aspirin was given on the first day of admission to patients with intermediate illness severity, researchers discovered a 1.6 percent reduction in mortality and that patients were less likely to form blood clots. They also discovered that individuals who are elderly or have one or more comorbidities benefit the most from early aspirin medication.
Overall, the researchers found that treatment with aspirin was responsible for a 13.6 percent reduction in the probability of death from covid-19 based on their findings. However, the findings of this current study bolstered the findings of two previous research on the subject.
According to the researchers, one advantage of the discovery is that acetylsalicylic acid (the well-known Aspirin) is inexpensive and readily available, which is critical for those who cannot afford therapy.
“This research is vital to providing physicians and patients effective and accessible COVID-19 treatments to help reduce in-hospital mortality rates and help people recover from this potentially devastating disease.”
What are the benefits of Aspirin?
The medicine is commonly used to treat fever and slight pain, although it can also be used as an anti-inflammatory or anticoagulant. Although studies have shown that sustained use of the drug can reduce the risk of cardiovascular problems, the FDA (US health agency) advises that this be done only under the guidance of a doctor.
Doctors frequently prescribe aspirin after a heart attack or stroke to prevent the formation of clots and the loss of heart tissue.
Image Credit: Getty
You were reading: Aspirin reduces risk of death from covid-19 – study finds